OSTEOPROTEGERIN AS A PROGNOSTIC MARKER IN PATIENTS WITH BREAST CANCER

Radwa Mohammed Gaber;

Abstract


Breast cancer is the third most common cancer in the world, and in 65% to 75% of patients, with progressive disease, bone metastases are common.

Osteoclastogenesis (as the first step of establishment of micro-metastasis) occurs when tumor cells chem


Other data

Title OSTEOPROTEGERIN AS A PROGNOSTIC MARKER IN PATIENTS WITH BREAST CANCER
Other Titles دور الاستيوبروتيجرين كدلالةعلى تطورالمرض في مرضى سرطان الثدى
Authors Radwa Mohammed Gaber
Keywords OSTEOPROTEGERIN AS A PROGNOSTIC MARKER IN PATIENTS WITH BREAST CANCER
Issue Date 2012
Description 
Breast cancer is the third most common cancer in the world, and in 65% to 75% of patients, with progressive disease, bone metastases are common.

Osteoclastogenesis (as the first step of establishment of micro-metastasis) occurs when tumor cells chem

Attached Files

File SizeFormat
111284R7285.pdf267.74 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.